Evidence map›Paper›PMID 41277219›Full record

ArticleBrain : a journal of neurology2026

Cerebrospinal fluid-driven ependymal motile cilia defects are implicated in multiple sclerosis.

Maxime Bigotte, Adam M R Groh, Elia Afanasiev, Vincent Wong, Kevin Lancon, Moein Yaqubi, Finn Creeggan, Airton Sinott, Junze Pei, Craig S Moore and 12 more

Abstract read
In one paragraph

Article in Brain : a journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Maxime BigotteDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.ORCID 0000-0001-5210-4264
Adam M R GrohDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.ORCID 0000-0002-5878-0973
Elia AfanasievDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.
Vincent WongDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.
Kevin LanconDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, Alan Edwards Centre for Research on Pain, McGill University, Montréal, QC, Canada H3A 2B4.
Moein YaqubiDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.
Finn CreegganDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.
Airton SinottDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.ORCID 0000-0003-0733-2940
Junze PeiDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.
Craig S MooreDivision of BioMedical Sciences, Faculty of Medicine, Memorial University of Newfoundland, St.John's, NL, Canada A1B 3V6.ORCID 0000-0003-3333-435X
Adil HarroudDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.ORCID 0000-0003-2616-7274
Raphael SchneiderSt.Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada M5B 1W8.
Philippe SéguélaDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, Alan Edwards Centre for Research on Pain, McGill University, Montréal, QC, Canada H3A 2B4.
Marc CharabatiCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Department of Neurosciences, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada H2X 0A9.ORCID 0000-0002-0451-6296
Fiona TeaCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Department of Neurosciences, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada H2X 0A9.
Antoine P FournierCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Department of Neurosciences, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada H2X 0A9.
Yu Chang WangVictor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, QC, Canada H3A OC7.
Jiannis RagoussisVictor Phillip Dahdaleh Institute of Genomic Medicine, McGill University, Montreal, QC, Canada H3A OC7.ORCID 0000-0002-8515-0934
Alexandre PratCentre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM) and Department of Neurosciences, Faculty of Medicine, Université de Montréal, Montreal, QC, Canada H2X 0A9.
Simon ThebaultDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.
Stephanie ZandeeDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.
Jo Anne StrattonDepartment of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada H3A 2B4.ORCID 0000-0002-1205-1353

Funding

Canadian Institute of Health ResearchFonds de Recherche du Quebec-SantéLe Grand PortageMS CanadaNatural Sciences and Engineering Research Council of Canada
6 · The paper itself

Abstract

Multiple sclerosis (MS) is a disorder of the CNS in which autoreactive immune cells migrate through a damaged blood-brain barrier, resulting in focal demyelinating lesions. Beyond focal lesions, there are also diffuse 'surface-in' gradients of pathology in MS, wherein damage is most severe directly adjacent to CSF-contacting surfaces, such as the subpial and periventricular areas. This observation suggests that toxic factors within MS CSF contribute to the emergence and/or evolution of surface-in gradients. Directly separating the CSF from the periventricular parenchyma are ependymal cells-a glial epithelium-that are equipped with tufts of motile cilia, which are critical for circulating CSF solutes and regulating local fluid flow. While damage to ependymal cilia has the potential to drastically modify CSF homeostasis and thus contribute to the damage of CSF exposed regions, these motile cellular structures have yet to be investigated in the context of MS. We first conducted single-cell RNA sequencing of fresh human periventricular brain tissue containing ependymal cells from patients with MS and non-MS disease controls. We subsequently collected CSF from patients with MS and exposed cultured rodent ependymal cells to this CSF to evaluate the impact on ependymal ciliary function. To complement our direct evaluation of cilia in the context of MS, we also confirmed whether cilia were altered in an animal model of MS, experimental autoimmune encephalomyelitis (EAE), and designed a novel transgenic animal model to evaluate the cellular and behavioural effect(s) of adult ependymal ciliary disruption. Single-cell RNA sequencing analysis of human ependymal cells in MS demonstrated large-scale dysregulation of ciliary genes, and in situ stains of MS brain tissue confirmed a loss of ependymal cilia. Exposure of ependymal cells to MS CSF led to transcriptional modification of ciliary gene and protein expression and reduced ciliary beating frequency. Likewise, analysis of ependymal cells in EAE demonstrated altered cilia gene and protein expression. We showed that IFNγ, which is elevated in MS CSF, could alter cilia protein expression and motility. Lastly, conditional knockout of Ccdc39 in ependymal cells of adult mice led to transient ventricular enlargement, increased periventricular microglial density and alterations in nesting behaviour. These data suggest that motile cilia in ependymal cells are dysregulated in CNS autoimmunity. More importantly, they suggest that ependymal cilia disruption could play a role in periventricular pathology formation in MS and be associated with behavioural deficits underlying non-motor symptomatology.

Indexed as

Cerebrospinal FluidCiliaEpendymaMultiple SclerosisAdultAnimalsEncephalomyelitis, Autoimmune, ExperimentalFemaleHumansMaleMiceMice, Inbred C57BLMiddle Agedcell culturecerebrospinal fluid barrierependymaepithelialneuroinflammationsingle-cell RNAseq

Identifiers

PMID41277219
PMCPMC13431679

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.